Signal Genetics, Inc.
$8.5 M
IPO
Sole Book-Runner
1347 Property Insurance Holdings, Inc.
$23 M
Secondary/Follow-On
Sole Book-Runner
Top Ships, Inc.
$21.3 M
Secondary/Follow-On
Sole Book-Runner
Corbus Pharmaceuticals Holdings, Inc
$10.3 M
Private Placement
Sorrento Therapeutics, Inc.
$28.8 M
Secondary/Follow-On
Sole Book-Runner
InVivo Therapeutics Holdings Corp.
$16.1 M
Secondary/Follow-On
Sole Book-Runner
San Luis Facility Development Corporation
$26.1 M
New Issue
Aldeyra Therapeutics, Inc.
$12 M
IPO
Sole Book-Runner
Intellicheck Mobilisa, Inc.
$2.1 M
Secondary/Follow-On
Sole Book-Runner
1347 Property Insurance Holdings, Inc.
$17.4 M
IPO
Sole Book-Runner
Advaxis, Inc.
$14.1 M
Secondary/Follow-On
Sole Book-Runner
Recro Pharma, Inc.
$34.5 M
IPO
Sole Book-Runner